Skip to content

Effect of Remote Ischemic Preconditioning on Electrophysiological and Biomolecular Parameters in Non-valvular Paroxysmal Atrial Fibrillation: RIPPAF Study

Effect of Remote Ischemic Preconditioning on Electrophysiological and Biomolecular Parameters in Non-valvular Paroxysmal Atrial Fibrillation: RIPPAF Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02779660
Acronym
RIPPAF
Enrollment
146
Registered
2016-05-20
Start date
2016-05-31
Completion date
2018-09-30
Last updated
2017-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Atrial Fibrillation

Brief summary

The aim of the study is to examine the effect of RIPC on physiological parameters in non-valvular paroxysmal atrial fibrillation. Furthermore the study will provide a unique bio-date base for further analysis of molecular and genetic mechanisms responsible for observed results. The potential effect of RIPC on AF inducibility and/or prothrombotic activity might be implemented as additional treatment component to reduce AF burden and minimize thromboembolic risk. Interim Analysis will be done after 73 patients.

Interventions

PROCEDURERemote ischemic preconditioning (RIPC)

RIPC will be induced by the application of 3 short episodes (5 minutes) of forearm ischemia by cuff sphygmomanometer inflation separated by 5 minutes of reperfusion.

In the control group the cuff will be inflated for 3 times at 10 mm Hg for 5 minutes with 5-minute intervals

Sponsors

Jedrzej Kosiuk
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* planned invasive Atrial Fibrillation ablation

Exclusion criteria

* AF in ECG at Admission * history of AF ablation * age \<18 * pregnancy * neoplastic disorders * acute or systemic inflammation, autoimmune diseases * documented atrial flutter

Design outcomes

Primary

MeasureTime frame
inducibility of Atrial Fibrillation by high-rate pacing of 20 sduring the Atrial Fibrillation Ablation procedure
sustainability of Atrial Fibrillation measured in secondsduring the Atrial Fibrillation Ablation procedure

Countries

Germany

Contacts

Primary ContactJedrzej Kosiuk, MD
Jedrzej.Kosiuk@helios-kliniken.de

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026